INS and type 2 diabetes mellitus: A 2020 Cochrane review [32] concluded that there was insufficient evidence to determine the safety and efficacy of resveratrol supplementation for treatment of T2D, with no statistically significant difference between resveratrol and placebo for HbA1c, FBG, or insulin resistance (three trials, n = 50).